Back
Metagenomi Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
26
MGX
Metagenomi Therapeutics, Inc.
Last Price:
$1.46
Seasonality Move:
-34.72%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MGX is experiencing selling pressure, which indicates risk of future bearish movement.
Metagenomi Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.5 | Sell |
| 20-day SMA: | 1.58 | Sell |
| 50-day SMA: | 1.66 | Sell |
| 200-day SMA: | 1.92 | Sell |
| 8-day EMA: | 1.51 | Sell |
| 20-day EMA: | 1.57 | Sell |
| 50-day EMA: | 1.69 | Sell |
| 200-day EMA: | 2.1 | Sell |
Metagenomi Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 37.93 | Sell |
| Chaikin Money Flow: | -206630 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.5 - 1.72) | Sell |
| Bollinger Bands (100): | (1.5 - 2.54) | Sell |
Metagenomi Therapeutics, Inc. Technical Analysis
| Jan 30 | Feb 2 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | Feb | |||||||||
| 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Metagenomi Therapeutics, Inc. Stock
Is Metagenomi Therapeutics, Inc. Stock a Buy?
-
Metagenomi Therapeutics, Inc. share price is 1.45 while MGX 8-day simple moving average is 1.50, which is a Sell signal.
-
The stock price of MGX is 1.45 while Metagenomi Therapeutics, Inc. 20-day SMA is 1.58, which makes it a Sell.
-
Metagenomi Therapeutics, Inc. 50-day simple moving average is 1.66 while MGX share price is 1.45, making it a Sell technically.
-
MGX stock price is 1.45 and Metagenomi Therapeutics, Inc. 200-day simple moving average is 1.92, creating a Sell signal.
MGX Technical Analysis vs Fundamental Analysis
Sell
26
Metagenomi Therapeutics, Inc. (MGX)
is a Sell
Is Metagenomi Therapeutics, Inc. a Buy or a Sell?
-
Metagenomi Therapeutics, Inc. stock is rated a SellThe current Metagenomi Therapeutics, Inc. [MGX] share price is $1.45. The Score for MGX is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
Metagenomi Therapeutics, Inc. Stock Info
Market Cap:
54.4M
Price in USD:
1.45
Share Volume:
258.3K
Metagenomi Therapeutics, Inc. 52-Week Range
52-Week High:
3.95
52-Week Low:
1.23
Sell
26
Metagenomi Therapeutics, Inc. (MGX)
is a Sell
Metagenomi Therapeutics, Inc. Share Price Forecast
-
What is the Metagenomi Therapeutics, Inc. stock price today?The Metagenomi Therapeutics, Inc. stock price is 1.45 USD today.
-
Will MGX stock go up or go down?Metagenomi Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Metagenomi Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Metagenomi Therapeutics, Inc. is overvalued.
Is Metagenomi Therapeutics, Inc. Stock a Buy?
-
Metagenomi Therapeutics, Inc. share price is 1.45 while MGX 8-day exponential moving average is 1.51, which is a Sell signal.
-
The stock price of MGX is 1.45 while Metagenomi Therapeutics, Inc. 20-day EMA is 1.57, which makes it a Sell.
-
Metagenomi Therapeutics, Inc. 50-day exponential moving average is 1.69 while MGX share price is 1.45, making it a Sell technically.
-
MGX stock price is 1.45 and Metagenomi Therapeutics, Inc. 200-day simple moving average is 2.10, creating a Sell signal.
Fundamental Analysis of Metagenomi Therapeutics, Inc.
Is Metagenomi Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.51 per share, and an increase next year of $0.37 per share.
Technical Analysis of Metagenomi Therapeutics, Inc.
Should I short Metagenomi Therapeutics, Inc. stock?
-
MGX Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting Metagenomi Therapeutics, Inc. is a Sell
-
Metagenomi Therapeutics, Inc. Relative Strength Index (RSI) is 37.93, which suggest Metagenomi Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Metagenomi Therapeutics, Inc. is (1.5 - 1.72), which suggest Metagenomi Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Metagenomi Therapeutics, Inc. is (1.5 - 2.54), which suggest Metagenomi Therapeutics, Inc. is a Sell
* Metagenomi Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.